CraniUS appoints Dr. Henry Brem to its Board of Directors

– USA, MD –  CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and treatments for patients with chronic brain disease, today announced the appointment of Dr. Henry Brem (M.D.) to its Board of Directors.

About Dr. Henry Brem

As the Harvey Cushing, Professor of Neurosurgery and Neurosurgeon-in-Chief at The Johns Hopkins Hospital, Dr. Brem brings along a wealth of knowledge and unmatched experience in Neurosurgery, Neuro-oncology, and Neurotechnology development.

Over the last several decades, Dr. Brem has built one of the world’s largest and most prestigious brain tumor centers. His efforts in leading academic researchers and industry collaborators have brought forward many game-changing modalities today in use worldwide.

Prior to Dr. Brem’s accomplishments, brain tumor chemotherapy was only prescribed, managed, and delivered by neuro-oncologists in either an oral pill or peripheral vein injection. In working with the Food and Drug Administration and Center for Medicare Services, he was the first to develop the Gliadel wafer for intraoperative placement of biodegradable chemotherapy wafers inside brain tumor cavities by neurosurgeons.

“I am absolutely thrilled to be joining the CraniUS Board of Directors. In this highly challenging space of chronic brain disease – forever restrained by the blood-brain barrier – this talented team will revolutionize our field by providing a disruptive platform technology through a fully implantable, MRI-compatible, and wirelessly charged device,” said Dr. Henry Brem.

About CraniUS

CraniUS’ stated mission is to invent and engineer world-class technology to define the future of diagnostics and treatments for patients with chronic brain disease. Its flagship device is being specifically developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. CraniUS utilizes a novel pump design and wireless charging technology to enable long-term and direct medicine administration via CED (convection-enhanced delivery), a safe and effective method of medicine delivery first introduced by the National Institute of Health. CraniUS was co-founded in May 2021 in Baltimore, MD, by Dr. Chad Gordon, the pioneer behind the emerging field known as “Neuroplastic and Reconstructive Surgery,” and CraniUS Chief Technology Officer, Deborah Weidman.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.